Atomoxetine and DAW2022 on OSA Severity
Condition(s):Obstructive Sleep ApneaLast Updated:July 7, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Obstructive Sleep ApneaLast Updated:July 7, 2023Recruiting
Condition(s):Obesity, MorbidLast Updated:March 27, 2023Recruiting
Condition(s):Tourette SyndromeLast Updated:January 23, 2024Terminated
Condition(s):OSALast Updated:October 17, 2023Not yet recruiting
Condition(s):Continuous Methamphetamine Dependence; Methamphetamine Dependence in RemissionLast Updated:May 12, 2016Completed
Condition(s):Alcohol Use DisorderLast Updated:March 22, 2023Active, not recruiting
Condition(s):Atomoxetine Hydrochloride; PlacebosLast Updated:August 14, 2017Completed
Condition(s):Mild Cognitive ImpairmentLast Updated:July 23, 2019Completed
Condition(s):Memory Disorders; Multiple SclerosisLast Updated:March 13, 2020Completed
Condition(s):Neurogenic Orthostatic HypotensionLast Updated:April 5, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.